NASDAQ:BOLT

Bolt Biotherapeutics . Stock Forecast

etoro logo Buy BOLT
*Your capital is at risk
$3.85
-0.0550 (-1.41%)
At Close: Jun 30, 2026
AI Analysis AI Analysis of BOLT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BOLT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Bolt Biotherapeutics, Inc. stock price down 1.41% on Tuesday
(Updated on Jun 30, 2026)

Sell candidate since Jun 03, 2026 Loss -16.85%

The Bolt Biotherapeutics, Inc. stock price fell by -1.41% on the last day (Tuesday, 30th Jun 2026) from $3.91 to $3.85. During the last trading day the stock fluctuated 9.80% from a day low at $3.82 to a day high of $4.19. The price has fallen in 7 of the last 10 days and is down by -16.12% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -61 thousand shares and in total, 18 thousand shares were bought and sold for approximately $69.31 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.59 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.14% during the next 3 months and, with a 90% probability hold a price between $3.30 and $4.64 at the end of this 3-month period.

BOLT Signals & Forecast

There are few to no technical positive signals at the moment. The Bolt Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.10 and $4.62. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 22, 2026, and so far it has fallen -28.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Bolt Biotherapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.374 between high and low, or 9.80%. For the last week the stock has had daily average volatility of 7.71%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BOLT) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Bolt Biotherapeutics, Inc. to open at $3.95, and during the day (based on 14 day Average True Range), to move between $3.67 and $4.03, which gives a possible trading interval of +/-$0.368 (+/-10.04%) up or down from last closing price. If Bolt Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 10.04% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.21, some $0.360 (9.35%) from the current price of $3.85, our system finds the risk reward not very attractive.

Is Bolt Biotherapeutics, Inc. stock A Buy?

Bolt Biotherapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.840 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $3.95 ( 2.72%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BOLT Performance

Trading levels for BOLT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.33 12.45%
R2 4.19 8.73%
R1 4.10 6.44%
Price 3.85
S1 3.81 -0.99%
S2 3.72 -3.29%
S3 3.58 -7.00%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.77 23.90%
R2 4.61 19.74%
R1 4.21 9.35%
Price 3.85
S1 0 -
S2 0 -
S3 0 -

BOLT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Aug 13, 2014 Aug 29, 2014 Oct 02, 2014 $0.0900 0%
2 Apr 24, 2014 Jun 10, 2014 Jul 09, 2014 $0.0900 0%
3 Jan 22, 2014 Mar 03, 2014 Apr 02, 2014 $0.0900 0%
4 Nov 27, 2013 Dec 30, 2013 Jan 15, 2014 $0.0900 0%
5 Aug 14, 2013 Sep 03, 2013 Oct 03, 2013 $0.0900 0%

FAQ

What is the symbol for Bolt Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Bolt Biotherapeutics, Inc. is BOLT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bolt Biotherapeutics, Inc. Stock?
Bolt Biotherapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Bolt Biotherapeutics, Inc. Stock?
Bolt Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bolt Biotherapeutics, Inc. Stock.

What's the current price of Bolt Biotherapeutics, Inc. Stock?
As of the end of day on the Jun 30, 2026, the price of an Bolt Biotherapeutics, Inc. (BOLT) share was $3.85.

What is the 52-week high and low for Bolt Biotherapeutics, Inc. Stock?
The 52-week high for Bolt Biotherapeutics, Inc. Stock is $7.20 and the 52-week low is $3.75.

What is the market capitalization of Bolt Biotherapeutics, Inc. Stock?
As of the Jun 30, 2026, the market capitalization of Bolt Biotherapeutics, Inc. is 7.398M.

When is the next earnings date for Bolt Biotherapeutics, Inc. ?
The upcoming earnings date for Bolt Biotherapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BOLT BIOTHERAPEUTICS, INC.
Bolt Biotherapeutics .
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for col...
GOLDEN STAR
Ticker Change Signal Date
OSIS
$218.29
0.188% Jun 26
IIIV
$20.09
6.32% Jun 25
JLL
$299.78
3.39% Jun 24
NMRK
$15.02
0.599% Jun 24
X
XMAX
$8.34
8.99% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE